Detalhe da pesquisa
1.
Rationale and design of PROACT Xa: A randomized, multicenter, open-label, clinical trial to evaluate the efficacy and safety of apixaban versus warfarin in patients with a mechanical On-X Aortic Heart Valve.
Am Heart J
; 227: 91-99, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32693197